Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Total Current Liabilities: 2018-2024

Historic Total Current Liabilities for Neurogene (NGNE) over the last 4 years, with Dec 2024 value amounting to $15.2 million.

  • Neurogene's Total Current Liabilities fell 6.90% to $14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year decrease of 6.90%. This contributed to the annual value of $15.2 million for FY2024, which is 34.02% down from last year.
  • As of FY2024, Neurogene's Total Current Liabilities stood at $15.2 million, which was down 34.02% from $23.0 million recorded in FY2023.
  • Neurogene's Total Current Liabilities' 5-year high stood at $23.0 million during FY2023, with a 5-year trough of $15.2 million in FY2024.
  • Over the past 2 years, Neurogene's median Total Current Liabilities value was $19.1 million (recorded in 2023), while the average stood at $19.1 million.
  • Data for Neurogene's Total Current Liabilities shows a maximum YoY crashed of 34.02% (in 2024) over the last 5 years.
  • Over the past 2 years, Neurogene's Total Current Liabilities (Yearly) stood at $23.0 million in 2023, then slumped by 34.02% to $15.2 million in 2024.